Immune Evasion by Cancer Cells as an Important Hallmark for Cancer Biology
12 May 2020

Immune Evasion by Cancer Cells as an Important Hallmark for Cancer Biology

by | posted in: Cancer, Coursework | 0

In order to proliferate, survive and become a clinically detectable tumour, cancer cells must have to devise strategies to evade the immunosurveillance imposed by the immune system. Consequently, considerable efforts have been made in our understanding of how cancer cells evade immune destruction, which has given insights into how to specifically target cancer cells using our body’s natural defenses; a field that is broadly classified as cancer immunotherapy.

Challenges and Promises of Targeting Cancer Stem Cells – the Proposed Achilles’ Heel of Cancer
22 Apr 2020

Challenges and Promises of Targeting Cancer Stem Cells – the Proposed Achilles’ Heel of Cancer

by | posted in: Cancer, Coursework | 0

Studies in the past two decades have identified a subpopulation of cancer cells called cancer stem cells (CSCs) or tumour-initiating cells (TICs) as being solely responsible for tumour initiation, progression, relapse, metastasis and drug resistance . Consequently, selective targeting of CSCs within the tumour cell population was initially thought to be a very promising therapeutic strategy to treating cancer.

Three Hypoxia Researchers share the 2019 Nobel Prize in Medicine or Physiology
16 Oct 2019

Three Hypoxia Researchers share the 2019 Nobel Prize in Medicine or Physiology

by | posted in: Cancer, Novel Discoveries | 0

The 2019 Nobel Prize in Medicine or Physiology has been jointly awarded to three scientists: William G. Kaelin Jr., professor of medicine at Dana-Farber Cancer Institute and Brigham & Women’s Hospital Harvard Medical School; Sir Peter J. Ratcliffe, director of clinical research at the Francis Crick Institute in London and director of the Target Discovery Institute at Oxford; and Gregg L. Semenza, professor of genetic medicine at Johns Hopkins –  for their work on how cells sense and adapt to oxygen availability.

ERBB2 Gene Amplification Plays a Role in Breast Cancer Development and Treatment
12 Oct 2017

ERBB2 Gene Amplification Plays a Role in Breast Cancer Development and Treatment

by | posted in: Cancer, Coursework | 0

  Introduction Cancer can be defined as a heterogeneous group of genetic diseases characterised by unregulated clonal expansion of somatic cells brought about by multiple genetic and epigenetic changes [1].  Cancer development and progression in humans involves multi-step processes that … Continued